BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

540737

SGRL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Shree Ganesh Remedies Limited Share Price Update

As of the latest trading session, Shree Ganesh Remedies Limited share price is currently at ₹ 734, which is up by ₹ 1.75 from its previous closing. Today, the stock has fluctuated between ₹ 715.00 and ₹ 760.05. Over the past year, Shree Ganesh Remedies Limited has achieved a return of 17.99 %. In the last month alone, the return has been 0.48 %. Read More...

Shree Ganesh Remedies Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    942.98

  • P/E Ratio (TTM)

    32.59

  • Beta

    1.00

  • Book Value / share

    103.72

  • Return on equity

    26.87%

  • EPS (TTM)

    22.66

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    5.43

info icon alternate text

Shree Ganesh Remedies Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 27.05
Operating Expense 20.23
Net Profit 5.43
Net Profit Margin (%) 20.07
Earnings Per Share (EPS) 4.23
EBITDA 10.62
Effective Tax Rate (%) 27.85
Particulars SEP 2024 (Values in Cr)
Revenue 32.33
Operating Expense 23.88
Net Profit 6.42
Net Profit Margin (%) 19.85
Earnings Per Share (EPS) 4.98
EBITDA 11.50
Effective Tax Rate (%) 25.78
Particulars JUN 2024 (Values in Cr)
Revenue 24.78
Operating Expense 18.99
Net Profit 4.65
Net Profit Margin (%) 18.76
Earnings Per Share (EPS) 3.62
EBITDA 8.67
Effective Tax Rate (%) 26.54
Particulars MAR 2024 (Values in Cr)
Revenue 37.33
Operating Expense 22.41
Net Profit 12.59
Net Profit Margin (%) 33.72
Earnings Per Share (EPS) 10.01
EBITDA 18.25
Effective Tax Rate (%) 22.52
Particulars DEC 2023 (Values in Cr)
Revenue 27.97
Operating Expense 21.66
Net Profit 4.80
Net Profit Margin (%) 17.16
Earnings Per Share (EPS) 3.52
EBITDA 9.32
Effective Tax Rate (%) 35.30
Particulars MAR 2024 (Values in Cr)
Revenue 125.90
Operating Expense 90.78
Net Profit 28.12
Net Profit Margin (%) 22.33
Earnings Per Share (EPS) 22.35
EBITDA 44.88
Effective Tax Rate (%) 26.32
Particulars MAR 2023 (Values in Cr)
Revenue 91.36
Operating Expense 71.84
Net Profit 15.18
Net Profit Margin (%) 16.61
Earnings Per Share (EPS) 12.54
EBITDA 24.15
Effective Tax Rate (%) 24.95
Particulars MAR 2022 (Values in Cr)
Revenue 71.29
Operating Expense 56.86
Net Profit 13.40
Net Profit Margin (%) 18.79
Earnings Per Share (EPS) 11.16
EBITDA 21.50
Effective Tax Rate (%) 25.59
Particulars MAR 2021 (Values in Cr)
Revenue 49.08
Operating Expense 38.23
Net Profit 9.75
Net Profit Margin (%) 19.86
Earnings Per Share (EPS) 9.75
EBITDA 15.75
Effective Tax Rate (%) 24.71
Particulars MAR 2020 (Values in Cr)
Revenue 58.43
Operating Expense 49.86
Net Profit 9.62
Net Profit Margin (%) 16.46
Earnings Per Share (EPS) 9.62
EBITDA 15.12
Effective Tax Rate (%) 24.48
Particulars MAR 2024 (Values in Cr)
Book Value / Share 95.07
ROE % 23.02
ROCE % 24.40
Total Debt to Total Equity 0.30
EBITDA Margin 35.65
Particulars MAR 2020 (Values in Cr)
Book Value / Share 47.04
ROE % 27.55
ROCE % 34.65
Total Debt to Total Equity 0.07
EBITDA Margin 25.65
Particulars MAR 2019 (Values in Cr)
Book Value / Share 37.70
ROE % 18.45
ROCE % 25.54
Total Debt to Total Equity 0.02
EBITDA Margin 28.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 95.07
ROE % 26.87
ROCE % 27.76
Total Debt to Total Equity 0.33
EBITDA Margin 35.65
Particulars MAR 2023 (Values in Cr)
Book Value / Share 69.70
ROE % 20.41
ROCE % 22.40
Total Debt to Total Equity 0.22
EBITDA Margin 26.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 51.28
ROE % 24.02
ROCE % 32.38
Total Debt to Total Equity 0.00
EBITDA Margin 30.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 49.97
ROE % 21.17
ROCE % 27.42
Total Debt to Total Equity 0.03
EBITDA Margin 32.07
Particulars MAR 2020 (Values in Cr)
Book Value / Share 46.92
ROE % 25.35
ROCE % 32.48
Total Debt to Total Equity 0.04
EBITDA Margin 25.88
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 16.26
Total Assets 170.93
Total Liabilities 170.93
Total Equity 122.09
Share Outstanding 12847198
Price to Book Ratio 7.02
Return on Assets (%) 16.44
Return on Capital (%) 17.74
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2.32
Total Assets 55.27
Total Liabilities 55.27
Total Equity 42.24
Share Outstanding 8971356
Price to Book Ratio 1.55
Return on Assets (%) 18.94
Return on Capital (%) 22.51
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.99
Total Assets 41.34
Total Liabilities 41.34
Total Equity 33.82
Share Outstanding 8971356
Price to Book Ratio 1.44
Return on Assets (%) 15.08
Return on Capital (%) 18.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 16.18
Total Assets 170.94
Total Liabilities 170.94
Total Equity 122.10
Share Outstanding 12847198
Price to Book Ratio 7.02
Return on Assets (%) 16.44
Return on Capital (%) 17.75
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.54
Total Assets 137.97
Total Liabilities 137.97
Total Equity 87.19
Share Outstanding 12006735
Price to Book Ratio 3.58
Return on Assets (%) 11.00
Return on Capital (%) 12.63
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.88
Total Assets 77.01
Total Liabilities 77.01
Total Equity 61.57
Share Outstanding 12006727
Price to Book Ratio 5.78
Return on Assets (%) 17.39
Return on Capital (%) 21.76
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.46
Total Assets 60.59
Total Liabilities 60.59
Total Equity 50.00
Share Outstanding 10006446
Price to Book Ratio 6.70
Return on Assets (%) 16.09
Return on Capital (%) 19.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.75
Total Assets 52.25
Total Liabilities 52.25
Total Equity 42.09
Share Outstanding 8971356
Price to Book Ratio 1.55
Return on Assets (%) 18.41
Return on Capital (%) 21.77
Particulars MAR 2024 (Values in Cr)
Net Income 38.16
Cash from Operations 30.44
Cash from Investing -33.00
Cash from Financing 9.84
Net change in Cash 7.28
Free Cash Flow 61.58
Particulars MAR 2020 (Values in Cr)
Net Income 10.47
Cash from Operations 4.58
Cash from Investing -2.90
Cash from Financing -0.47
Net change in Cash 1.20
Free Cash Flow 4.63
Particulars MAR 2019 (Values in Cr)
Net Income 6.23
Cash from Operations -5.21
Cash from Investing -0.07
Cash from Financing -0.17
Net change in Cash -5.46
Free Cash Flow -5.11
Particulars MAR 2024 (Values in Cr)
Net Income 38.16
Cash from Operations 30.44
Cash from Investing -33.09
Cash from Financing 9.85
Net change in Cash 7.20
Free Cash Flow 61.58
Particulars MAR 2023 (Values in Cr)
Net Income 20.23
Cash from Operations 17.09
Cash from Investing -51.08
Cash from Financing 38.65
Net change in Cash 4.67
Free Cash Flow 66.23
Particulars MAR 2022 (Values in Cr)
Net Income 18.00
Cash from Operations 13.41
Cash from Investing -11.91
Cash from Financing -1.08
Net change in Cash 0.41
Free Cash Flow 28.74
Particulars MAR 2021 (Values in Cr)
Net Income 12.94
Cash from Operations 3.31
Cash from Investing -0.94
Cash from Financing -0.65
Net change in Cash 1.71
Free Cash Flow 3.32
Particulars MAR 2020 (Values in Cr)
Net Income 12.74
Cash from Operations 3.87
Cash from Investing -2.90
Cash from Financing -0.20
Net change in Cash 0.75
Free Cash Flow 3.92
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

Shree Ganesh Remedies Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
738.45 0.84 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 741.40
  • 26 Days 730.10
  • 10 Days 740.30
  • 50 Days 726.70
  • 12 Days 738.60
  • 100 Days 729.30
  • 20 Days 732.70
  • 200 Days 724.40
732.40 PIVOT

First Support

716.85

First Resistance

747.80

Second Support

701.45

Second Resistance

763.35

Third Support

685.90

Third Resistance

778.75

RSI

50.71

ADX

23.79

MACD

9.19

Williams % R

-53.79

Commodity Channel Index (CCI)

13.01

Date

2025-04-29

Week

4201.00

Same Day

1759.00

Month

5741.00

1 Year

1.01

3 Year

0.65

Over 1 Month

0.48%

down

Over 1 Year

17.99%

down

Over 3 Months

5.90%

down

Over 3 Years

31.57%

down

Over 6 Months

-4.80%

down

Over 5 Years

72.30%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Shree Ganesh Remedies Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
27.19%
Promoter Holdings
72.79%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Chandulal Manubhai Kothia 6259016.0 (48.76%) Shareholding of Promoter and Promoter Group
Hanshaben Chandubhai Kothia 1467754.0 (11.43%) Shareholding of Promoter and Promoter Group
Pooja Gunjan Kothia 615000.0 (4.79%) Shareholding of Promoter and Promoter Group
Gunjan Chandulal Kothia 411583.0 (3.21%) Shareholding of Promoter and Promoter Group
Manubhai Jivabhai Kothiya 236510.0 (1.84%) Shareholding of Promoter and Promoter Group
Gunjan Jayantibhai Dhorajiya 218000.0 (1.7%) Public Shareholding
Hetvi Ketankumar Patel 213409.0 (1.66%) Shareholding of Promoter and Promoter Group
V Naga Raja Naidu 161150.0 (1.26%) Public Shareholding
Parth Chandulal Kothia 131704.0 (1.03%) Shareholding of Promoter and Promoter Group
Kothia Ashokkumar Manubhai (huf) 10568.0 (0.08%) Shareholding of Promoter and Promoter Group
Vilasben Ashokkumar Kothia 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Shree Ganesh Remedies Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
07 Sep 2023 0.5 Final 07 Sep 2023 Equity shares
15 Sep 2022 0.5 Final 16 Sep 2022 Equity shares
08 Sep 2021 1.75 Final 11 Sep 2021 Equity shares
01 Sep 2020 1.5 Final 02 Sep 2020 Equity shares
22 Aug 2019 1.25 Final 24 Aug 2019 Equity shares
19 Sep 2018 1.0 Final 22 Sep 2018 Equity shares
Ex-Date Ex-Bonus Ratio
02 Nov 2021 01 Nov 2021 1:5
07 Oct 2020 06 Oct 2020 3:26
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Shree Ganesh Remedies Limited Share Price

Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995. Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017. The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals.

Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral. The Products are manufactured for export market and also for domestic and foreign markets. The Company entered the International market in 2006 and are on regular basis exporting its products to various countries.

The manufacturing facility is divided into three manufacturing plants namely Plant I, II and III spread across 9715 square meters having different product manufacturing capabilities and process. The manufacturing process is supported by Total Quality Management techniques and is supervised through various quality control equipment's and qualified personnel. The Products are manufactured for export market and also for domestic and foreign markets.

In October 2017, the Company came up with a Public Issue of 23,76,000 Fresh Equity Shares by raising equity funds aggregating to Rs 8.56 Crores.

In Unit I, Plant 5 was commissioned and made operational in 2018. In 2019, the Company started commercial production at the new production plant at GIDC, Ankleshwar. It acquired Ashok Pharma Chem (Partnership Firm) on December 24, 2019. In 2020, it launched New Advance Pharmaceutical Intermediates substituting the import intermediates. High Pressure Reaction Block was commissioned in 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 1995
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Shree Ganesh Remedies Ltd?

Answer Field

The share price of Shree Ganesh Remedies Ltd for NSE is ₹ 0.00 and for BSE is ₹ 738.45.

What is the Market Cap of Shree Ganesh Remedies Ltd?

Answer Field

The market cap of Shree Ganesh Remedies Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 9,47.90 Cr. as of now.

What is the 52 Week High and Low of Shree Ganesh Remedies Ltd?

Answer Field

The 52 Week High and Low of Shree Ganesh Remedies Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 950.05 and ₹ 557.95.

How to Buy Shree Ganesh Remedies Ltd share?

Answer Field

You can trade in Shree Ganesh Remedies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shree Ganesh Remedies Ltd?

Answer Field

The 1 year returns on the stock has been 20.02%.

What is the Current Share Price of Shree Ganesh Remedies Ltd?

Answer Field

Shree Ganesh Remedies Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 738.45 as on Apr 30 2025 03:28 PM.

What is the Market Cap of Shree Ganesh Remedies Ltd Share?

Answer Field

The market cap of Shree Ganesh Remedies Ltd for NSE ₹ 0.0 & for BSE ₹ 9,47.90 as on Apr 30 2025 03:28 PM.

What is the P/E Ratio of Shree Ganesh Remedies Ltd Share?

Answer Field

As on Apr 30 2025 03:28 PM the price-to-earnings (PE) ratio for Shree Ganesh Remedies Ltd share is 32.59.

What is the PB ratio of Shree Ganesh Remedies Ltd Share?

Answer Field

As on Apr 30 2025 03:28 PM, the price-to-book (PB) ratio for Shree Ganesh Remedies Ltd share is 103.72.

How to Buy Shree Ganesh Remedies Ltd Share?

Answer Field

You can trade in Shree Ganesh Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shree Ganesh Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Shree Ganesh Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shree Ganesh Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|